Calibre What Science Can Do

This website contains promotional content about AstraZeneca Medications. This website is intended for healthcare professionals involved in the Acute Coronary Syndrome care pathway, such as hospital specialists from cardiology and cardiology-related departments, including A&E and elderly care, as well as GPs with a specific interest in cardiology, nurses, pharmacists and payers with budget responsibilities in cardiology.

ACS expert on-demand Webinars

Recorded content from live events from notable speakers

 

July 2018

ACS and ongoing atherothrombotic risk from the front door - Part 1
Dr. Nick Pegge

Biography

Dr. Nick Pegge

Qualified from Jesus College, Cambridge and St Thomas', London.

Postgraduate training at Royal Sussex County Hospital, Brighton; Royal Free Hospital and St George's Hospital, London; Singleton and Morriston Hospitals, Swansea; University Hospital of Wales, Cardiff.

Fellowship in Interventional Cardiology, University Hospital, Frankfurt am Main, Germany (2003).

Professional interests: all forms of cardiology, especially coronary intervention, heart failure, arrhythmias, pacing and complex device therapy.

Expert witness for GMC.

Chair of Trust Joint Private Practice Committee.

Professional memberships: British Cardiovascular Society, British Cardiovascular Intervention Society, European Society of Cardiology.

ACS and ongoing atherothrombotic risk from the front door - Part 2 Dr. Nick Pegge

Biography

Dr. Nick Pegge

Qualified from Jesus College, Cambridge and St Thomas', London.

Postgraduate training at Royal Sussex County Hospital, Brighton; Royal Free Hospital and St George's Hospital, London; Singleton and Morriston Hospitals, Swansea; University Hospital of Wales, Cardiff.

Fellowship in Interventional Cardiology, University Hospital, Frankfurt am Main, Germany (2003).

Professional interests: all forms of cardiology, especially coronary intervention, heart failure, arrhythmias, pacing and complex device therapy.

Expert witness for GMC.

Chair of Trust Joint Private Practice Committee.

Professional memberships: British Cardiovascular Society, British Cardiovascular Intervention Society, European Society of Cardiology.

The transition from acute to secondary prevention: Support, care and pathways—the pharmacist view
Dr. Rani Khatib

Biography

Dr. Rani Khatib

A consultant pharmacist in cardiology and cardiovascular research. He leads several innovative cardiology medicines optimisation services across secondary and primary care in Leeds. Well published, research grants holder, principal investigator and co-investigator of several trials with specific interest in medicine adherence. UK Clinical Pharmacy Association, Cardiology Group, committee member. Science committee member at the European Society of Cardiology-Council on Cardiovascular Nursing and Allied Professions. Member of NICE Chronic Heart Failure Guideline Committee. Earned multiple recognitions and awards for innovation and excellence in patient care. Honorary Senior Lecturer at the University of Leeds and Honorary Clinical Research Fellow at the University of Bradford.

January 2018

The why, when and how of antiplatelet therapy in high-risk, post-myocardial infarction patients
Prof Christopher Gale

Biography

Prof Christopher Gale

Prof Christopher Gale is a professor of cardiovascular medicine at the Division of Epidemiology, University of Leeds. He is also an honorary consultant cardiologist and leads the Medical Research Council (MRC) Bioinformatics Centre’s Cardiovascular Epidemiology group. 

Prof Gale qualified in medicine at the London Hospital Medical College and obtained a BSc (Hons) in psychology. After working as a junior doctor at the Royal London Hospital and becoming a member of the Royal College of Physicians, he became a MRC clinical training fellow and undertook a PhD in molecular biology at the University of Leeds. Prof Gale undertook specialty training in cardiology at the Leeds General Infirmary, where he was a NIHR academic clinical lecturer. He holds a Master’s in clinical education and a Master’s in statistical epidemiology. As a consultant cardiologist, he completed a 5-year NIHR Clinician Scientist Award to become an NIHR clinical trials fellow.

Prof Gale has published over 100 original research papers and is Deputy Editor of European Heart Journal – Quality of Care and Clinical Outcomes. Prof Gale is Chair of the research committee of the National Institute for Cardiovascular Outcomes Research. In addition to membership of the National Institute for Health and Care Excellence Indicator Advisory Committee, he is an oversight committee member of the European Society of Cardiology (ESC) EURObservational Research Programme and Secretary of the ESC Acute Cardiovascular Care Association.

The why, when and how of antiplatelet therapy in high-risk, post-myocardial infarction patients Professor Philippe Gabriel Steg

Biography

Professor Philippe Gabriel Steg

Dr Philippe Gabriel Steg is a professor of cardiology at Université Paris Diderot and the National Heart and Lung Institute of Imperial College London. He is also an interventional cardiologist and Chief of the Cardiology Department at Hôpital Bichat, Assistance Publique-Hôpitaux de Paris. 

Dr Steg participates in the leadership of many trials in coronary artery disease and is currently Chair/co-Chair or principal investigator of several large clinical trials or registries such as ODYSSEY Outcomes, CLARIFY, THEMIS, REALITY, and SCORED. He is Chair of the FACT: French Alliance for Cardiovascular Clinical Trials academic research network, was co-Chair of the REACH registry and the GRACE registry publication committee, and participated in numerous data monitoring committees or clinical events committees.

Dr Steg is co-Coordinator of the Département Hospitalo-Universitaire FIRE affiliated with INSERM, Université Paris Diderot and Assistance Publique – Hôpitaux de Paris, and Coordinator of the iVASC research consortium. He has authored over 1,000 articles in international peer-reviewed journals, is Associate Editor for Circulation and on the editorial board for the European Heart Journal. He received the silver medal of the European Society of Cardiology (ESC) in 2011 and co-chaired the ESC task force in charge of the 2012 Guidelines for management of ST-segment elevation myocardial infarction.

October 2017

Individualised patient approaches for DAPT: duration beyond 12 months
Dr Dominick Angiolillo

Biography

Dr Dominick Angiolillo

Dr Angiolillo joined the University of Florida College of Medicine – Jacksonville in 2004. Currently, Dr Angiolillo is a Professor of Medicine with tenure status. He is also the Director of Cardiovascular Research, Program Director of the Interventional Cardiology Fellowship Program and a Staff Cardiologist and Interventional Cardiologist with the University of Florida Health System. Dr. Angiolillo is board certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease and interventional cardiology.

Individualised patient approaches for DAPT; duration to 12 months Dr Christopher Granger

Biography

Dr Christopher Granger

Dr. Granger, MD is a Professor of Medicine in the Division of Cardiology and a member of the Duke Clinical Research Institute, Duke University School of Medicine in North Carolina, USA. Dr. Granger is a Fellow of the American College of Cardiology, the American Heart Association and of the European Society of Cardiology. His primary research interests are in the conduct and methodology of large randomized trials in heart disease. He is Associate Editor of the American Heart Journal and serves on the editorial board of the Journal of American College of Cardiology.